Millennium Management’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,051,846
| Closed | -$105K | – | 5679 |
|
|
2025
Q4 | $105K | Sell |
1,051,846
-855,368
| -45% | -$544K | ﹤0.01% | 5628 |
|
|
2025
Q3 | $1.15M | Sell |
1,907,214
-37,690
| -2% | -$17.8K | ﹤0.01% | 4510 |
|
|
2025
Q2 | $605K | Buy |
1,944,904
+1,835,806
| +1,683% | +$710K | ﹤0.01% | 4771 |
|
|
2025
Q1 | $53.3K | Sell |
109,098
-1,220,051
| -92% | -$718K | ﹤0.01% | 5533 |
|
|
2024
Q4 | $1.14M | Buy |
1,329,149
+1,051,779
| +379% | +$6.59M | ﹤0.01% | 4093 |
|
|
2024
Q3 | $2.36M | Buy |
277,370
+166,462
| +150% | +$981K | ﹤0.01% | 3555 |
|
|
2024
Q2 | $518K | Sell |
110,908
-815,517
| -88% | -$3.86M | ﹤0.01% | 4563 |
|
|
2024
Q1 | $6.3M | Buy |
926,425
+326,387
| +54% | +$1.47M | ﹤0.01% | 2647 |
|
|
2023
Q4 | $2.01M | Buy |
+600,038
| New | +$1.49M | ﹤0.01% | 3603 |
|
|
2023
Q3 | – | Sell |
-47,760
| Closed | -$61.1K | – | 6086 |
|
|
2023
Q2 | $61.1K | Sell |
47,760
-134,066
| -74% | -$178K | ﹤0.01% | 5435 |
|
|
2023
Q1 | $147K | Buy |
181,826
+119,883
| +194% | +$118K | ﹤0.01% | 5286 |
|
|
2022
Q4 | $47K | Sell |
61,943
-37,538
| -38% | -$29.7K | ﹤0.01% | 5791 |
|
|
2022
Q3 | $93K | Sell |
99,481
-261,333
| -72% | -$313K | ﹤0.01% | 5992 |
|
|
2022
Q2 | $342K | Buy |
360,814
+252,718
| +234% | +$414K | ﹤0.01% | 5257 |
|
|
2022
Q1 | $228K | Buy |
108,096
+37,735
| +54% | +$101K | ﹤0.01% | 5758 |
|
|
2021
Q4 | $630K | Buy |
70,361
+58,428
| +490% | +$767K | ﹤0.01% | 4842 |
|
|
2021
Q3 | $198K | Buy |
+11,933
| New | +$206K | ﹤0.01% | 6118 |
|
|
2021
Q2 | – | Sell |
-19,334
| Closed | -$363K | – | 6488 |
|
|
2021
Q1 | $363K | Sell |
19,334
-63,959
| -77% | -$1.38M | ﹤0.01% | 5084 |
|
|
2020
Q4 | $1.83M | Buy |
83,293
+50,628
| +155% | +$1.05M | ﹤0.01% | 3307 |
|
|
2020
Q3 | $678 | Buy |
32,665
+18,904
| +137% | +$491K | ﹤0.01% | 3402 |
|
|
2020
Q2 | $497K | Sell |
13,761
-75,563
| -85% | -$3.16M | ﹤0.01% | 3405 |
|
|
2020
Q1 | $2.92M | Buy |
+89,324
| New | +$3.61M | 0.01% | 1749 |
|
|
2019
Q4 | – | Sell |
-26,290
| Closed | -$288K | – | 4178 |
|
|
2019
Q3 | $288K | Sell |
26,290
-29,945
| -53% | -$283K | ﹤0.01% | 3592 |
|
|
2019
Q2 | $463K | Buy |
+56,235
| New | +$532K | ﹤0.01% | 3288 |
|
Millennium Management's APLT Position: Q1 2026 in Review
Millennium Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 1,051,846 shares — an estimated $105K sold.
Millennium Management first reported a position in APLT in Q2 2019 and held it in 24 quarters. The position peaked at $6.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Millennium Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 1,051,846 Applied Therapeutics shares in Q1 2026, an estimated $105K.
- Millennium Management first reported a position in Applied Therapeutics in Q2 2019 and held it in 24 quarters.
- Millennium Management's Applied Therapeutics position peaked at $6.3M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.